Makarasen, A.; Kuno, M.; Patnin, S.; Reukngam, N.; Khlaychan, P.; Deeyohe, S.; Intachote, P.; Saimanee, B.; Sengsai, S.; Boonsri, P.; Chaivisuthangkura, A.; Sirithana, W.; Techasakul, S. Molecular Docking Studies and Synthesis of Amino-Oxy-Diarylquinoline Derivatives as Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors. Drug Res. 2019, 69, 671–682.

28 Dec 2019
0
0

Makarasen, A.; Kuno, M.; Patnin, S.; Reukngam, N.; Khlaychan, P.; Deeyohe, S.; Intachote, P.; Saimanee, B.; Sengsai, S.; Boonsri, P.; Chaivisuthangkura, A.; Sirithana, W.; Techasakul, S. Molecular Docking Studies and Synthesis of Amino-Oxy-Diarylquinoline Derivatives as Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors. Drug Res. 2019, 69, 671–682.

Tags

Share this

Related Posts

Epigallocatechin gallate-zinc oxide co-crystalline nanoparticles as an anticancer drug that is non-toxic to normal cells. Samutprasert P, Chiablaem K, Teeraseranee C, Phaiyarin P, Pukfukdee P, Pienpinijtham P, Svasti J, Palaga T, Lirdprapamongkol K, Wanichwecharungruang S*. RSC Adv. 2018;8(14):7369-7376
15 Feb 2018
0

Epigallocatechin gallate-zinc oxide co-crystalline nanoparticles as an anticancer drug that is non-toxic to normal cells. Samutprasert P, Chiablaem K, Teeraseranee C, Phaiyarin P, Pukfukdee P, Pienpinijtham P, Svasti J, Palaga T, Lirdprapamongkol K, Wanichwecharungruang S*. RSC Adv. 2018;8(14):7369-7376

Epigallocatechin gallate-zinc oxide co-crystalline nanoparticles as an anticancer drug that is non-toxic to normal cells. Samutprasert P, Chiablaem K, Teeraseranee C, Phaiyarin P, Pukfukdee P, Pienpinijtham P, Svasti J, Palaga T, Lirdprapamongkol K, Wanichwecharungruang S*. RSC Adv. 2018;8(14):7369-7376
View More

Recent Posts